| scholarly article | Q13442814 |
| P50 | author | David D Roberts | Q42408238 |
| P2093 | author name string | Jeffrey S Isenberg | |
| Natasha M Rogers | |||
| Elsa D Garcin | |||
| Franziska Seeger | |||
| P2860 | cites work | Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: influence of nitric oxide scavengers and calcium | Q73399151 |
| Cyclic nucleotide-gated channels mediate membrane depolarization following activation of store-operated calcium entry in endothelial cells | Q73675926 | ||
| CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1 | Q74165103 | ||
| Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses | Q79837874 | ||
| Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia | Q83853842 | ||
| [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs] | Q84237651 | ||
| Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure | Q84553919 | ||
| The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases | Q87203045 | ||
| Isolation and characterization of a high molecular weight glycoprotein from human blood platelets | Q22009134 | ||
| Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake | Q24302047 | ||
| The L-arginine-nitric oxide pathway | Q24304874 | ||
| Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner | Q24321591 | ||
| Crystal structures of the catalytic domain of human soluble guanylate cyclase | Q24336722 | ||
| A thrombin-sensitive protein of human platelet membranes | Q24609538 | ||
| Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors | Q24633525 | ||
| NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 | ||
| Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity | Q24674570 | ||
| A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer | Q27319501 | ||
| NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism | Q27641107 | ||
| PAS-mediated Dimerization of Soluble Guanylyl Cyclase Revealed by Signal Transduction Histidine Kinase Domain Crystal Structure | Q27649070 | ||
| Crystal structure of the guanylyl cyclase Cya2 | Q27652450 | ||
| The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase | Q27652454 | ||
| Probing the Function of Heme Distortion in the H-NOX Family | Q27652988 | ||
| A structural basis for H-NOX signaling in Shewanella oneidensis by trapping a histidine kinase inhibitory conformation | Q27658207 | ||
| Determinants of Ligand Affinity and Heme Reactivity in H-NOX Domains | Q27658678 | ||
| Crystal structure of the signaling helix coiled-coil domain of the β1 subunit of the soluble guanylyl cyclase | Q27659219 | ||
| Structural insights into the molecular mechanism of H-NOX activation | Q27659887 | ||
| Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase | Q27661554 | ||
| Controlling Conformational Flexibility of an O 2 -Binding H-NOX Domain | Q27670635 | ||
| Tunnels modulate ligand flux in a heme nitric oxide/oxygen binding (H-NOX) domain | Q27675023 | ||
| Insights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes | Q27677544 | ||
| Crystal structure of the Alpha subunit PAS domain from soluble guanylyl cyclase | Q27679506 | ||
| Interfacial residues promote an optimal alignment of the catalytic center in human soluble guanylate cyclase: heterodimerization is required but not sufficient for activity | Q27682500 | ||
| Role of CD47 as a marker of self on red blood cells | Q28138449 | ||
| Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking | Q36713981 | ||
| Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease | Q36725128 | ||
| Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates | Q36748594 | ||
| Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses | Q69932605 | ||
| Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro | Q70687871 | ||
| Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide | Q70930193 | ||
| Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase | Q71239563 | ||
| Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells | Q72224272 | ||
| Reversible inactivation of guanylate cyclase by mixed disulfide formation | Q72457078 | ||
| Evidence for phosphorylation of rat brain guanylate cyclase by cyclic AMP-dependent protein kinase | Q72508228 | ||
| Effect of GTP analogues on purified soluble guanylate cyclase | Q72519691 | ||
| Electron paramagnetic resonance spectral evidence for the formation of a pentacoordinate nitrosyl-heme complex on soluble guanylate cyclase | Q72566480 | ||
| Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin | Q72572414 | ||
| Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation | Q73081040 | ||
| A molecular basis for nitric oxide sensing by soluble guanylate cyclase | Q36774286 | ||
| Recruitment of Nox4 to a plasma membrane scaffold is required for localized reactive oxygen species generation and sustained Src activation in response to insulin-like growth factor-I. | Q36890594 | ||
| H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase | Q36895184 | ||
| Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling. | Q36955405 | ||
| Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation | Q36997217 | ||
| Pathobiology of pulmonary hypertension | Q37014730 | ||
| Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses. | Q37036482 | ||
| The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics | Q37048314 | ||
| Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress | Q37144638 | ||
| Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1 | Q37162361 | ||
| Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? | Q37293823 | ||
| Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies | Q37385797 | ||
| Characterization of two different five-coordinate soluble guanylate cyclase ferrous-nitrosyl complexes | Q37395595 | ||
| Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation | Q37400455 | ||
| Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin | Q37409425 | ||
| A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase | Q37467778 | ||
| Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective. | Q37477176 | ||
| Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases | Q37511692 | ||
| Hydrogen sulfide regulates Ca(2+) homeostasis mediated by concomitantly produced nitric oxide via a novel synergistic pathway in exocrine pancreas | Q37543214 | ||
| YC-1 binding to the β subunit of soluble guanylyl cyclase overcomes allosteric inhibition by the α subunit. | Q37557818 | ||
| A second thrombospondin gene in the mouse is similar in organization to thrombospondin 1 but does not respond to serum | Q37600090 | ||
| Single-particle EM reveals the higher-order domain architecture of soluble guanylate cyclase | Q37612777 | ||
| Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity | Q37712434 | ||
| Binding of YC-1/BAY 41-2272 to soluble guanylate cyclase: A new perspective to the mechanism of activation | Q37761752 | ||
| Electronic structure of heme-nitrosyls and its significance for nitric oxide reactivity, sensing, transport, and toxicity in biological systems | Q37776256 | ||
| Soluble guanylate cyclase modulators in heart failure | Q37826122 | ||
| Riociguat for the treatment of pulmonary hypertension. | Q37851516 | ||
| Adhesion-modulating/matricellular ECM protein families: a structural, functional and evolutionary appraisal. | Q37977744 | ||
| Structure and regulation of soluble guanylate cyclase | Q37992160 | ||
| Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. | Q38041505 | ||
| Novel aspects of dietary nitrate and human health | Q38103950 | ||
| Soluble guanylate cyclase stimulators in pulmonary hypertension | Q38149032 | ||
| Riociguat for pulmonary hypertension | Q38192059 | ||
| Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin | Q38807815 | ||
| Expression and characterization of the catalytic domains of soluble guanylate cyclase: interaction with the heme domain | Q39369792 | ||
| Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats | Q28145149 | ||
| Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase | Q28188797 | ||
| Integrin-associated protein (CD47) and its ligands | Q28212839 | ||
| Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells | Q28237012 | ||
| CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1 | Q28251463 | ||
| Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains | Q28278085 | ||
| AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase | Q28283420 | ||
| Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties | Q28300388 | ||
| Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner | Q28476620 | ||
| Identification of residues in the heme domain of soluble guanylyl cyclase that are important for basal and stimulated catalytic activity | Q28477878 | ||
| Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes | Q28565964 | ||
| The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells | Q28582206 | ||
| Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress | Q29615436 | ||
| Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase | Q30427519 | ||
| Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations | Q30449094 | ||
| Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration | Q30503997 | ||
| Higher-order interactions bridge the nitric oxide receptor and catalytic domains of soluble guanylate cyclase. | Q30539237 | ||
| Riociguat for the treatment of pulmonary arterial hypertension | Q33163083 | ||
| Characterization of a novel type of endogenous activator of soluble guanylyl cyclase | Q33208407 | ||
| Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts | Q33312205 | ||
| Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling | Q33392798 | ||
| Molecular regulation of tumor angiogenesis and perfusion via redox signaling | Q33572306 | ||
| Fluorescent fusion proteins of soluble guanylyl cyclase indicate proximity of the heme nitric oxide domain and catalytic domain | Q33640041 | ||
| Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury | Q33660552 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase | Q33772904 | ||
| Guanylyl cyclases and signaling by cyclic GMP. | Q33917038 | ||
| Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP | Q33948069 | ||
| How do heme-protein sensors exclude oxygen? Lessons learned from cytochrome c', Nostoc puntiforme heme nitric oxide/oxygen-binding domain, and soluble guanylyl cyclase | Q34166721 | ||
| Nitric oxide insufficiency, platelet activation, and arterial thrombosis | Q34234301 | ||
| Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation | Q34275612 | ||
| Cyanide toxicity from sodium nitroprusside: risks and management | Q34344067 | ||
| Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. | Q34385843 | ||
| Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites | Q34449038 | ||
| The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure | Q39790834 | ||
| Superoxide fluxes limit nitric oxide-induced signaling | Q40257194 | ||
| NO activation of guanylyl cyclase | Q40327686 | ||
| Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. | Q40448208 | ||
| Intracellular cyclic GMP receptor proteins. | Q40485121 | ||
| Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides. | Q40586309 | ||
| Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain | Q40617757 | ||
| Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization | Q40630407 | ||
| A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. | Q40657503 | ||
| Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. | Q40951409 | ||
| Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains | Q41283869 | ||
| Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway | Q41329824 | ||
| Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite | Q41531752 | ||
| Nitric oxide activation of guanylate cyclase pushes the α1 signaling helix and the β1 heme-binding domain closer to the substrate-binding site. | Q41848414 | ||
| Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. | Q41891843 | ||
| Inhibition of soluble guanylate cyclase by ODQ. | Q42055822 | ||
| Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione s-transferase affinity tag. | Q42058515 | ||
| Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin | Q42059639 | ||
| Matricellular proteins: an overview | Q42096914 | ||
| Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. | Q42194066 | ||
| Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | Q42275867 | ||
| Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity. | Q42439086 | ||
| Expression of soluble guanylate cyclase activity requires both enzyme subunits | Q42464263 | ||
| Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance | Q42544768 | ||
| Inhibition of nitric oxide-activated guanylyl cyclase by calmodulin antagonists. | Q42951381 | ||
| A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. | Q43491083 | ||
| Calcium ion downregulates soluble guanylyl cyclase activity: evidence for a two-metal ion catalytic mechanism | Q43614080 | ||
| c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. | Q43652228 | ||
| Role of cyclic-GMP in relaxations of vascular smooth muscle | Q43860562 | ||
| Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calcium. | Q43904218 | ||
| Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide | Q43911622 | ||
| Inhibition of deactivation of NO-sensitive guanylyl cyclase accounts for the sensitizing effect of YC-1. | Q43972677 | ||
| Recognition of the N-terminal modules of thrombospondin-1 and thrombospondin-2 by alpha6beta1 integrin. | Q44543826 | ||
| An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs | Q44553283 | ||
| Modulation of soluble guanylate cyclase activity by phosphorylation | Q44904313 | ||
| Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase | Q44935032 | ||
| Femtomolar sensitivity of a NO sensor from Clostridium botulinum. | Q45096466 | ||
| Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase | Q45223552 | ||
| Activation of CD47 receptors causes histamine secretion from mast cells | Q46127263 | ||
| Inactivation of soluble guanylate cyclase by stoichiometric S-nitrosation | Q46180158 | ||
| Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta | Q46390975 | ||
| Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes. | Q46544029 | ||
| Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase | Q46633532 | ||
| Control of coronary vascular tone by nitric oxide. | Q46687645 | ||
| Thiol oxidation inhibits nitric oxide-mediated pulmonary artery relaxation and guanylate cyclase stimulation | Q46792295 | ||
| Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production | Q47863878 | ||
| Purifieation of a Soluble, Sodium-Nitroprusside-Stimulated Guanylate Cyclase from Bovine Lung | Q50939098 | ||
| Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase. | Q54282706 | ||
| Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization. | Q54579268 | ||
| Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to Ischemia | Q58315878 | ||
| Increasing Survival of Ischemic Tissue by Targeting CD47 | Q58315881 | ||
| Critical overexpression of thrombospondin 1 in chronic leg ischaemia | Q62996442 | ||
| Reversible activation of soluble guanylate cyclase by oxidizing agents | Q67514923 | ||
| Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. | Q34516854 | ||
| Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow | Q34527600 | ||
| Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction | Q34600570 | ||
| Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation | Q34686759 | ||
| Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension | Q34957241 | ||
| Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels | Q35009484 | ||
| Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease | Q35010064 | ||
| Membrane-association and the sensitivity of guanylyl cyclase-coupled receptors to nitric oxide | Q35047042 | ||
| Oxidation and loss of heme in soluble guanylyl cyclase from Manduca sexta | Q35083181 | ||
| Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses | Q35084643 | ||
| Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. | Q35121057 | ||
| Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase | Q35124292 | ||
| The thrombospondins. | Q35230013 | ||
| Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. | Q35379312 | ||
| Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta. | Q35529294 | ||
| Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension | Q35543584 | ||
| Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2 | Q35558854 | ||
| Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase [corrected]. | Q35575494 | ||
| Dynamic ligand exchange in soluble guanylyl cyclase (sGC): implications for sGC regulation and desensitization | Q35604613 | ||
| Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation | Q35642769 | ||
| Hydrogen sulfide is an endogenous potentiator of T cell activation | Q35763228 | ||
| Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. | Q35792731 | ||
| Nitric oxide insufficiency and atherothrombosis | Q35874972 | ||
| Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. | Q35902676 | ||
| Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation | Q35925811 | ||
| Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species | Q36052610 | ||
| Soluble guanylyl cyclase requires heat shock protein 90 for heme insertion during maturation of the NO-active enzyme | Q36167665 | ||
| Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury | Q36200946 | ||
| Nitric oxide in wound-healing. | Q36207435 | ||
| Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. | Q36223338 | ||
| Explaining the phenomenon of nitrate tolerance | Q36272905 | ||
| CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells | Q36276395 | ||
| Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling | Q36384766 | ||
| Targeting reactive oxygen species in hypertension | Q36398049 | ||
| Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells. | Q36496361 | ||
| P304 | page(s) | 134 | |
| P577 | publication date | 2014-04-04 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow | |
| P478 | volume | 5 |
| Q37057946 | A Common CD36 Variant Influences Endothelial Function and Response to Treatment with Phosphodiesterase 5 Inhibition |
| Q89964362 | Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review |
| Q35598298 | Down regulation of NO signaling in Trypanosoma cruzi upon parasite-extracellular matrix interaction: changes in protein modification by nitrosylation and nitration |
| Q48194277 | Effects of different-intensity laser acupuncture at two adjacent same-meridian acupoints on nitric oxide and soluble guanylate cyclase releases in human. |
| Q50019794 | Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions. |
| Q46706302 | Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu. |
| Q36480286 | Regulation of Neuronal Oxygen Responses in C. elegans Is Mediated through Interactions between Globin 5 and the H-NOX Domains of Soluble Guanylate Cyclases. |
| Q55009724 | Role of ROS and Nutritional Antioxidants in Human Diseases. |
| Q58614731 | The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury |
Search more.